The Children’s Tumor Foundation has been selected to take the stage as an ‘Innovator’ at ‘Partnering for Cures’ the Milken Institute forum that aims to transform the medical research system and accelerate cures by providing a partnering venue for foundations, industry and investors. Partnering for Cures had its inaugural meeting in 2009 and we are honored to be a selected speaker for the second year in a row.
CTF’s ‘Innovator Presentation’ will showcase progress to date in our Neurofibromatosis Preclinical Consortium (NFPC), CTF’s collaboration of six research centers conducting drug trials on models of different NF1 and NF2 related tumors. NFPC, CTF’s biggest investment to date at $4M+, has generated a number of exciting findings to date and has established collaborations with Novartis, Genentech, Avila Therapeutics and other industry entities that we hope will advance progress to NF clinical therapies.
